Evidence that the immediate biosynthetic precursor of clavulanic acid is its N-aldehyde analogue

Nicholson, Neville; Baggaley, Keith H.; Cassels, Robert; Davison, Mark; Elson, Stephen W.; Fulston, Mark; Tyler, John W.; Woroniecki, Stefan R.

doi:10.1039/c39940001281

Cited by 46 publications

(41 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The organization and control of the genes associated with penam or cephem formation in vivo and the functions of these individual gene products have been intensively studied (11). In contrast, considerably less is known about the biosynthesis of clavulanic acid, although several intermediates have been identified (12,14) and three enzyme activities involved in the mid and late stages of the biosynthesis have been isolated and purified (12,14,26,32). Among these, clavaminate synthase (CS) is of particular importance.…”

mentioning

confidence: 99%

Identification, cloning, sequencing, and overexpression of the gene encoding proclavaminate amidino hydrolase and characterization of protein function in clavulanic acid biosynthesis

Busby

Houston

et al. 1995

J Bacteriol

View full text Add to dashboard Cite

mentioning

confidence: 99%

Identification, cloning, sequencing, and overexpression of the gene encoding proclavaminate amidino hydrolase and characterization of protein function in clavulanic acid biosynthesis

Busby

Houston

et al. 1995

J Bacteriol

View full text Add to dashboard Cite

“…Clavaminic acid is thought to be the branch point of the pathway leading to clavulanic acid and the 5S clavams (10). The only other step known in the pathway beyond clavaminic acid is the reduction of clavaldehyde to clavulanic acid by the action of the enzyme clavulanic acid dehydrogenase (27), which is encoded by cad, a late gene from the clavulanic acid gene cluster (15). It is still not known how clavaminic acid is converted to clavaldehyde, nor have any of the steps specifically leading from clavaminic acid to the 5S clavams been elucidated (16).…”

mentioning

confidence: 99%

The Paralogous Pairs of Genes Involved in Clavulanic Acid and Clavam Metabolite Biosynthesis Are Differently Regulated in Streptomyces clavuligerus

2004

View full text Add to dashboard Cite

Carboxyethylarginine synthase, encoded by the paralogous ceaS1 and ceaS2 genes, catalyzes the first reaction in the shared biosynthetic pathway leading to clavulanic acid and the other clavam metabolites in Streptomyces clavuligerus. The nutritional regulation of ceaS1 and ceaS2 expression was analyzed by reverse transcriptase PCR and by the use of the enhanced green fluorescent protein-encoding gene (egfp) as a reporter. ceaS1 was transcribed in complex soy medium only, whereas ceaS2 was transcribed in both soy and defined starchasparagine (SA) media. The transcriptional start points of the two genes were also mapped to a C residue 98 bp upstream of ceaS1 and a G residue 51 bp upstream of the ceaS2 start codon by S1 nuclease protection and primer extension analyses. Furthermore, transcriptional mapping of the genes encoding the beta-lactam synthetase (bls1) and proclavaminate amidinohydrolase (pah1) isoenzymes from the paralogue gene cluster indicated that a single polycistronic transcript of ϳ4.9 kb includes ceaS1, bls1, and pah1. The expression of ceaS1 and ceaS2 in a mutant strain defective in the regulatory protein CcaR was also examined. ceaS1 transcription was not affected in the ccaR mutant, whereas that of ceaS2 was greatly reduced compared to the wild-type strain. Overall, our results suggest that different mechanisms are involved in regulating the expression of ceaS1 and ceaS2, and presumably also of other paralogous genes that encode proteins involved in the early stages of clavulanic acid and clavam metabolite biosynthesis.

show abstract

“…It synthesizes the ␤-lactam antibiotic cephamycin C, the ␤-lactamase inhibitor clavulanic acid, and several antifungal compounds with a clavam structure (for reviews, see references 3 and 15). The clavulanic acid biosynthesis pathway has several steps in common with the pathway for clavam biosynthesis (18,19). In addition to the compounds indicated above, S. clavuligerus produces the antibiotics holomycin and tunicamycin (10).…”

mentioning

confidence: 99%

Mutants of Streptomyces clavuligerus with Disruptions in Different Genes for Clavulanic Acid Biosynthesis Produce Large Amounts of Holomycin: Possible Cross-Regulation of Two Unrelated Secondary Metabolic Pathways

et al. 2002

View full text Add to dashboard Cite

A Streptomyces clavuligerus ccaR::aph strain, which has a disruption in the regulatory gene ccaR, does not produce cephamycin C or clavulanic acid, but does produce a bioactive compound that was identified as holomycin by high-performance liquid chromatography (HPLC) and infrared and mass spectrometry. S. clavuligerus strains with disruptions in different genes of the clavulanic acid pathway fall into three groups with respect to holomycin biosynthesis. (i) Mutants with mutations in the early steps of the pathway blocked in the gene ceaS (pyc) (encoding carboxyethylarginine synthase), bls (encoding a ␤-lactam synthetase), or open reading frame 6 (ORF6; coding for an acetyltransferase of unknown function) are holomycin nonproducers. (ii) Mutants blocked in the regulatory gene ccaR or claR or blocked in the last gene of the pathway encoding clavulanic acid reductase (car) produce holomycin at higher levels than the wild-type strain. (iii) Mutants with disruption in cyp (coding for cytochrome P450), ORF12, and ORF15, genes that appear to be involved in the conversion of clavaminic acid into clavaldehyde or in secretion steps, produce up to 250-fold as much holomycin as the wild-type strain. An assay for holomycin synthetase was developed. This enzyme forms holomycin from holothin by using acetyl coenzyme A as an acetyl group donor. The holomycin synthase activities in the different clavulanic acid mutants correlate well with their production of holomycin.Streptomyces clavuligerus produces several secondary metabolites with interesting pharmacological activities. It synthesizes the ␤-lactam antibiotic cephamycin C, the ␤-lactamase inhibitor clavulanic acid, and several antifungal compounds with a clavam structure (for reviews, see references 3 and 15). The clavulanic acid biosynthesis pathway has several steps in common with the pathway for clavam biosynthesis (18,19). In addition to the compounds indicated above, S. clavuligerus produces the antibiotics holomycin and tunicamycin (10). Holomycin is a compound with pyrrothine structure, while tunicamycin is a glucosamine-containing antibiotic. This wealth of genetic information for the biosynthesis of secondary metabolites is characteristic of some Streptomyces species (4, 22).S. clavuligerus is an excellent model for the study of the relationships between the regulatory mechanisms controlling the biosynthesis of the different secondary metabolites produced by these microorganisms. Formation of clavulanic acid is controlled by a LysR-type regulatory protein encoded by the claR gene. Formation of both clavulanic acid and cephamycin C in S. clavuligerus is controlled by the positive autoregulatory protein CcaR (25, 32). Mutant strains with disruption in ccaR do not express the claR gene (26), although this control is not exerted directly by the CcaR regulatory protein and appears to involve a cascade mechanism (32). The control of the formation of cephamycin C and/or clavulanic acid by CcaR or ClaR is exerted at the transcription level (1, 25).However, the ccaR::aph S....

show abstract

Evidence that the immediate biosynthetic precursor of clavulanic acid is its N-aldehyde analogue

Abstract: Clavulanate-9-aldehyde 1 has been detected in Streptomyces clavuligerus and an NADPH dependent dehydrogenase capable of reducing 1 to clavulanic acid 2 has been isolated from this organism.

Cited by 46 publications

References 4 publications

Identification, cloning, sequencing, and overexpression of the gene encoding proclavaminate amidino hydrolase and characterization of protein function in clavulanic acid biosynthesis

Identification, cloning, sequencing, and overexpression of the gene encoding proclavaminate amidino hydrolase and characterization of protein function in clavulanic acid biosynthesis

The Paralogous Pairs of Genes Involved in Clavulanic Acid and Clavam Metabolite Biosynthesis Are Differently Regulated in Streptomyces clavuligerus

Mutants of Streptomyces clavuligerus with Disruptions in Different Genes for Clavulanic Acid Biosynthesis Produce Large Amounts of Holomycin: Possible Cross-Regulation of Two Unrelated Secondary Metabolic Pathways

Contact Info

Product

Resources

About